News

Patient Advocacy @CTOS 2024

  We are delighted to announce that patient advocacy will once again have a valued presence at the Connective Tissue Oncology Society (CTOS) Annual Meeting. This year, we are pleased to host the Patient Advocacy Lounge at CTOS 2024 in San Diego:...
Read More ... about Patient Advocacy @CTOS 2024

ACF’s European Manifesto: Addressing Critical Gaps in Research and Treatment of Rare Cancers🎗️

The Anticancer Fund (ACF) has launched its European Manifesto 2024, presenting a forward-looking strategy to position Europe as a global leader in cancer treatment innovation. With cancer rates set to rise dramatically-35 million new cases projected by 2050-there's no time...
Read More ... about ACF’s European Manifesto: Addressing Critical Gaps in Research and Treatment of Rare Cancers🎗️

Key Findings from Phase II of the SPAGN Priority Setting Partnership published 📝

The Sarcoma Patient Advocacy Global Network (SPAGN) has published the results of the second phase of its Priority Setting Partnership (PSP), focusing on identifying research and patient advocacy priorities in sarcoma care, in "BMC Cancer". This initiative is groundbreaking as...
Read More ... about Key Findings from Phase II of the SPAGN Priority Setting Partnership published 📝

Save the Date: SPAGN Annual Conference 2025 in Washington D.C.!📅

We are thrilled to announce that the SPAGN Annual Conference 2025 will be held in Washington D.C., USA, from April 11-13, 2025. This will be our first conference in the United States, marking a significant milestone for our global community....
Read More ... about Save the Date: SPAGN Annual Conference 2025 in Washington D.C.!📅

Sarcoma Awareness Month 2024 is approaching quickly: Join our campaign!

Sarcoma Awareness Month is held annually in July, a time when the global sarcoma community comes together with a unified mission: to raise awareness about this rare and often overlooked group of cancers and to highlight the unique challenges faced...
Read More ... about Sarcoma Awareness Month 2024 is approaching quickly: Join our campaign!

What is a sarcoma specialist center?

On May 13, 2024, SPAGN published a paper in "Cancers" on the definition, core principles and features of a sarcoma specialist center, developed by patient advocates and healthcare professionals together. The management of sarcomas in specialist centers delivers significant benefits....
Read More ... about What is a sarcoma specialist center?

Join the SPAGN Editorial Blog Team: Volunteer Job Opportunity

VOLUNTEER JOB POSTING: Editors for the SPAGN Blog" Voices of Sarcoma" We are looking for volunteers to serve on the Editorial team of SPAGN's blog "Voices of Sarcoma".   Sarcoma Patient Advocacy Global Network (SPAGN) is the global network of...
Read More ... about Join the SPAGN Editorial Blog Team: Volunteer Job Opportunity

First Webinar “What is a Sarcoma?” in Spanish and Portuguese, March 22, 2024!

Nos complace anunciar nuestro primer webinar para pacientes con sarcoma, cuidadores y defensores de pacientes de América Central y del Sur, realizado en español y portugués por especialistas en sarcoma de Argentina y Brasil en esta ocasión. El webinar tendrá...
Read More ... about First Webinar “What is a Sarcoma?” in Spanish and Portuguese, March 22, 2024!

EU-X-CT – Patient Questionnaire – Borders should not be barriers to clinical trials

The EU-X-CT initiative aims at revolutionizing patient access to clinical trials across borders. But before we delve into the project details, we want to emphasize something crucial - your participation! The data is being collected through a Patient Questionnaire which...
Read More ... about EU-X-CT – Patient Questionnaire – Borders should not be barriers to clinical trials

Insights from the EMA and EORTC Workshop on Developing Treatments for Ultra-Rare Sarcomas

Author: Gerry Feeney How can we develop new treatments in ultra-rare sarcomas, as a model for ultra-rare tumors?   On January 12, 2024, a workshop between regulators, researchers and patient advocates was held at the European Medicines Agency (EMA) premises...
Read More ... about Insights from the EMA and EORTC Workshop on Developing Treatments for Ultra-Rare Sarcomas